Osteoprotegerin in juvenile rheumatoid arthritis: cross talk between the immune and the skeletal systems
Egyptian Journal of Pediatric Allergy and Immunology [The]. 2004; 2 (1): 38-45
en Inglés
| IMEMR
| ID: emr-205410
ABSTRACT
Background:
Previous studies have linked the decreased local production of osteoprotegerin [OPG], an osteoclastogenesis blocking agent, in the inflamed joints of rheumatoid arthritis patients to the development of bone erosion
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Egypt. J. Ped. Aller. Immunol.
Año:
2004
Similares
MEDLINE
...
LILACS
LIS